Eric J. Ende
Director, GENZYME CORP.
Companies
- Avadel PharmaceuticalsBoard member Jan 3, 2019 to now1
- Matinas BioPharma Holdings, Inc.Board member Apr 21, 2017 to Nov 3, 20232
- NeuBase Therapeutics, Inc.Board member Jan 5, 2022 to Sep 12, 20223
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Avadel Pharmaceuticals AVDL0 shares4Feb 12, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 12, 2026Returned to company 219,905 shares at $21.00 of Avadel Pharmaceuticals4
- Jul 29, 2025Granted 11,000 shares of Avadel Pharmaceuticals5
- Jan 13, 2025Bought 30,000 shares at $7.84 of Avadel Pharmaceuticals6
- Jul 30, 2024Granted 11,000 shares of Avadel Pharmaceuticals7
- May 18, 2023Bought 13,000 shares at $13.93 of Avadel Pharmaceuticals8
- Nov 22, 2022Bought 20,000 shares at $7.80 of Avadel Pharmaceuticals9
- Jun 1, 2022Bought 20,000 shares at $2.27 of Avadel Pharmaceuticals10
- May 31, 2022Bought 15,000 shares at $2.16 of Avadel Pharmaceuticals10
- May 27, 2022Bought 15,000 shares at $2.45 of Avadel Pharmaceuticals11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAvadel Pharmaceuticals, Board member
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Jul 31, 2025
- 6SEC EDGARForm 4 filed Jan 14, 2025
- 7SEC EDGARForm 4 filed Aug 1, 2024
- 8SEC EDGARForm 4 filed May 19, 2023
- 9SEC EDGARForm 4 filed Nov 23, 2022
- 10SEC EDGARForm 4 filed Jun 1, 2022
- 11SEC EDGARForm 4 filed May 31, 2022